Refresh

BLISS GVS PHARMA LTD. - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.


Download
13 Nov 2020
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 13, 2020 for Arjun Gautam Ashra

Source: BSE India

View all announcements for BLISS GVS PHARMA LTD.
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com